|
FAM178A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.61080054744889E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.9464986834048E-11 |
| Normal-vs-Stage2 |
5.218500E-04 |
| Normal-vs-Stage3 |
2.754300E-04 |
| Normal-vs-Stage4 |
6.031300E-04 |
| Stage1-vs-Stage2 |
8.287000E-01 |
| Stage1-vs-Stage3 |
1.922480E-02 |
| Stage1-vs-Stage4 |
5.084100E-02 |
| Stage2-vs-Stage3 |
2.201200E-01 |
| Stage2-vs-Stage4 |
2.603200E-01 |
| Stage3-vs-Stage4 |
9.293600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11330003391441E-09 |
| Normal-vs-AfricanAmerican |
3.61770000000261E-05 |
| Normal-vs-Asian |
1.55909996024661E-09 |
| Caucasian-vs-AfricanAmerican |
2.452600E-01 |
| Caucasian-vs-Asian |
4.339400E-03 |
| AfricanAmerican-vs-Asian |
3.104500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.88850000479601E-08 |
| Normal-vs-Female |
1.69629976731756E-10 |
| Male-vs-Female |
8.100000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.097600E-03 |
| Normal-vs-Age(41-60Yrs) |
9.18629616819544E-11 |
| Normal-vs-Age(61-80Yrs) |
4.94999999989254E-07 |
| Normal-vs-Age(81-100Yrs) |
2.389000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.737200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.931790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.218240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.202200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.547500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.637600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.849840E-04 |
| Normal-vs-Grade 2 |
6.13510353630886E-11 |
| Normal-vs-Grade 3 |
1.06259999999025E-06 |
| Normal-vs-Grade 4 |
3.743800E-03 |
| Grade 1-vs-Grade 2 |
2.898400E-02 |
| Grade 1-vs-Grade 3 |
3.577100E-04 |
| Grade 1-vs-Grade 4 |
3.994300E-04 |
| Grade 2-vs-Grade 3 |
1.594270E-02 |
| Grade 2-vs-Grade 4 |
2.064300E-02 |
| Grade 3-vs-Grade 4 |
4.286800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.86113363504137E-12 |
| Normal-vs-ccB subtype |
9.67929999999839E-05 |
| ccA subtype-vs-ccB subtype |
2.441400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.41000039106154E-10 |
| Normal-vs-N1 |
6.159600E-02 |
| N0-vs-N1 |
8.634400E-01 |
|
|
